HilleVax, Inc.
Total Trades
19
Buys
3
Sells
12
Largest Trade
N/A
Insiders
6
Institutional Funds
13
Inst. Value
$1M+
Activist Filings
27
Insider Trades
| Insider | Title | Type | Value | Shares | Price | Date |
|---|---|---|---|---|---|---|
| Kohli Aditya | Director | SELL | $100K–$500K | 18K | $14.79 | May 22, 2024 |
| Kohli Aditya | Director | SELL | $50K–$100K | 7K | $14.03 | May 3, 2024 |
| Frazier Life Sciences X, L.P. | 10% Owner | BUY | $100K–$500K | 9K | $14.50 | Apr 8, 2024 |
| Kohli Aditya | Director | SELL | $100K–$500K | 18K | $14.69 | Apr 5, 2024 |
| McLoughlin Sean | COO | BUY | $15K–$50K | 1K | $16.98 | Apr 1, 2024 |
| Kohli Aditya | Director | SELL | $1M+ | 18K | $54752.02 | Mar 20, 2024 |
| Kohli Aditya | Director | SELL | $100K–$500K | 18K | $14.95 | Feb 22, 2024 |
| Kohli Aditya | Director | SELL | $50K–$100K | 6K | $15.32 | Feb 14, 2024 |
| Kohli Aditya | Director | GRANT | N/A | 55K | — | Feb 13, 2024 |
| Kohli Aditya | Director | SELL | $100K–$500K | 9K | $14.93 | Feb 13, 2024 |
| Maltbie Shane | CFO | SELL | $50K–$100K | 4K | $14.93 | Feb 13, 2024 |
| Maltbie Shane | CFO | GRANT | N/A | 48K | — | Feb 13, 2024 |
| HERSHBERG ROBERT | See Remarks | SELL | $100K–$500K | 12K | $14.93 | Feb 13, 2024 |
| HERSHBERG ROBERT | See Remarks | GRANT | N/A | 174K | — | Feb 13, 2024 |
| Borkowski Astrid | Chief Medical Offi… | GRANT | N/A | 54K | — | Feb 13, 2024 |
| Borkowski Astrid | Chief Medical Offi… | SELL | $50K–$100K | 4K | $14.93 | Feb 13, 2024 |
| Borkowski Astrid | Chief Medical Offi… | SELL | $100K–$500K | 10K | $14.00 | Nov 20, 2023 |
| Borkowski Astrid | Chief Medical Offi… | SELL | $50K–$100K | 5K | $13.00 | Nov 13, 2023 |
| Frazier Life Sciences X, L.P. | 10% Owner | BUY | $1M+ | 1.8M | $17.00 | May 3, 2022 |
Institutional Ownership
13F filings as of Jun 30, 2025 · 13 funds holding
| Fund | Shares | Value | Type |
|---|---|---|---|
| Samsara BioCapital, LLC | 400K | $500K+ | SH |
| MILLENNIUM MANAGEMENT LLC | 176K | $100K–$500K | SH |
| Y-Intercept (Hong Kong) Ltd | 109K | $100K–$500K | SH |
| GSA CAPITAL PARTNERS LLP | 78K | $100K–$500K | SH |
| Squarepoint Ops LLC | 62K | $100K–$500K | SH |
| MORGAN STANLEY | 51K | $100K–$500K | SH |
| JANE STREET GROUP, LLC | 15K | $15K–$50K | SH |
| Callan Family Office, LLC | 12K | $15K–$50K | SH |
| CWM, LLC | 3K | $1K–$15K | SH |
| ROYAL BANK OF CANADA | 768 | $1K–$15K | SH |
| NISA INVESTMENT ADVISORS, LLC | 353 | <$1K | SH |
| Farther Finance Advisors, LLC | 207 | <$1K | SH |
| Private Wealth Management Group, LLC | 20 | <$1K | SH |
Activist & 5%+ Owners
SC 13D/13G filings — investors holding 5%+ of outstanding shares
SC 13G/A · Nov 14, 2025
0.0%
0 shares
SC 13D/A · Sep 19, 2025
0.0%
0 shares
Takeda Pharmaceutical Company Limited
SC 13D/A · Sep 19, 2025
0.0%
0 shares
Frazier Life Sciences Public Fund, L.P.
SC 13D/A · Sep 17, 2025
0.0%
0 shares
SC 13G · Jul 24, 2025
5.8%
2.9M shares
SC 13D · May 2, 2025
9.8%
4.9M shares
SC 13G/A · Nov 14, 2024
0.0%
0 shares
SC 13G/A · Nov 14, 2024
0.0%
0 shares
SC 13G · Jul 23, 2024
9.5%
4.7M shares
Frazier Life Sciences Public Fund, L.P. 2.
SC 13D/A · May 31, 2024
3.9%
1.9M shares
Lightspeed Venture Partners Select IV, L.P.
SC 13G/A · Feb 14, 2024
4.8%
2.3M shares
SC 13G/A · Feb 14, 2024
0.0%
0 shares
SC 13G/A · Feb 14, 2024
6.0%
2.9M shares
SC 13G/A · Feb 12, 2024
4.4%
2.1M shares
SC 13G/A · Feb 12, 2024
3.8%
1.8M shares
SC 13G · Sep 29, 2023
6.1%
2.9M shares
Frazier Life Sciences Public Fund, L.P. 2.
SC 13D/A · Sep 27, 2023
2.6%
1.2M shares
Frazier Life Sciences Public Fund, L.P.
SC 13D/A · May 5, 2023
3.2%
1.2M shares
SC 13G · Feb 14, 2023
5.3%
1.8M shares
SC 13G/A · Feb 10, 2023
5.5%
1.8M shares
SC 13G/A · Feb 10, 2023
2.4%
811K shares
Frazier Life Sciences Public Fund, L.P.
SC 13D/A · Sep 8, 2022
3.3%
1.1M shares
Lightspeed Venture Partners Select IV, L.P.
SC 13G · May 13, 2022
5.7%
1.9M shares
SC 13G · May 13, 2022
5.5%
1.8M shares
Takeda Pharmaceutical Company Limited
SC 13D · May 9, 2022
17.1%
6.7M shares
Frazier Life Sciences Public Fund, L.P.
SC 13D · May 6, 2022
1.8%
588K shares
SC 13G · May 3, 2022
2.2%
735K shares